It was registered an increase on Celldex Therapeutics Inc (NASDAQ:CLDX)’s short interest with 167.85%. It was published in March by FINRA the 383,300 short interest on CLDX. The 143,100 previous shares are up with 167.85%. 0 days will cost CLDX with 890,800 average volume to restore its former position. Celldex Therapeutics Inc’s short interest float is 3.35%.

The stock decreased 2.19% or $0.11 during the last trading session, reaching $4.92.Celldex Therapeutics, Inc. has volume of 164,891 shares. Since March 31, 2018 CLDX has declined 84.87% and is downtrending. The stock underperformed the S&P500 by 89.24%.

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics.The company has $61.20 million market cap. The Company’s drug candidates include glembatumumab vedotin, an antibody-drug that is in Phase IIb study for the treatment of triple negative breast cancer and a Phase II study for the treatment of metastatic melanoma; and Varlilumab, an immune modulating antibody that is in a Phase 1 study designed to enhance a patient's immune response against cancer.Currently it has negative earnings. It also develops earlier stage drug candidates in clinical development, including CDX-1401, an immunotherapeutic for cancer indications; CDX-301, an immune cell mobilizing agent and dendritic cell growth factor; and CDX-014, an antibody-drug conjugate targeting renal and ovarian cancers.

For more Celldex Therapeutics, Inc. (NASDAQ:CLDX) news posted recently go to: Benzinga.com, Nasdaq.com, Nasdaq.com, Fool.com or Nasdaq.com. The titles are as follows: “50 Stocks Moving In Friday’s Mid-Day Session – Benzinga” posted on March 08, 2019, “Celldex to Report Full Year 2018 Business/Financial Results and Host Corporate Update Call – Nasdaq” on March 01, 2019, “Celldex Therapeutics (CLDX) Down 9.2% Since Earnings Report: Can It Rebound? – Nasdaq” with a publish date: June 11, 2018, “Here’s Why Celldex Therapeutics, Inc. Surged on Thursday – Motley Fool” and the last “What’s in Store for Celldex (CLDX) This Earnings Season? – Nasdaq” with publication date: May 03, 2018.